Table 2.
Bohan and peter criteria for polymyositis and dermatomyositis.
| Cretirion | Polymyositis |
Dermatomyositis |
Details | ||
|---|---|---|---|---|---|
| Definite | Probable | Definite | Mild or early | ||
| Muscle strength | Myopathic muscle weakness | Myopathic muscle weakness | Myopathic muscle weakness | Seemingly normal strength | Symmetrical and progressive weakness of the proximal limb-girdle muscles |
| Electromyographic findings | Myopathic | Myopathic | Myopathic | Myopathic or nonspecific | Short duration, low amplitude polyphasic units; fibrillations, complex repetitive discharges; positive sharp waves |
| Muscle enzymes | Elevated (up to 50-fold) | Elevated (up to 50-fold) | Elevated (up to 50-fold) | Elevated (up to 10-fold) | Creatine kinase, aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, aldolase |
| Muscle-biology findings | Diagnostic for this type of inflammatory myopathy | Nonspecific myopathy without signs of primary inflammation | Diagnostic | Nonspecific or diagnostic | Perivascular, interfascicular or endomysial inflammatory infiltration; phagocytosis, necrosis, and regeneration of muscle fibers; capillary obliteration and endothelial damage |
| Rash or calcinosis | Absent | Absent | Present | Present | Heliotrope rash and Gottron’s sign/papules |